Resource


Open Access
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
View ORCID ProfileAlaknanda Adwal Correspondence email, View ORCID ProfilePriyakshi Kalita-de Croft, Reshma Shakya, Malcolm Lim, Emarene Kalaw, Lucinda D Taege, View ORCID ProfileAmy E McCart Reed, View ORCID ProfileSunil R Lakhani, David F Callen, View ORCID ProfileJodi M Saunus Correspondence email
Alaknanda Adwal
1The Robinson Research Institute, Adelaide Medical School, The University of Adelaide, Adelaide, Australia
Priyakshi Kalita-de Croft
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
Reshma Shakya
3QIMR Centre for Immunotherapy and Vaccine Development, Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Malcolm Lim
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
Emarene Kalaw
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
Lucinda D Taege
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
4Pathology Queensland, The Royal Brisbane and Women’s Hospital, Brisbane, Australia
Amy E McCart Reed
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
Sunil R Lakhani
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
4Pathology Queensland, The Royal Brisbane and Women’s Hospital, Brisbane, Australia
David F Callen
5School of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, Australia
Jodi M Saunus
2The University of Queensland (UQ) Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
Published 18 May 2020. DOI: 10.26508/lsa.201900562
Relevance of proteasome inhibitor therapy in TNBC
Alaknanda Adwal, Priyakshi Kalita-de Croft, Reshma Shakya, Malcolm Lim, Emarene Kalaw, Lucinda D Taege, Amy E McCart Reed, Sunil R Lakhani, David F Callen, Jodi M Saunus
Life Science Alliance May 2020, 3 (7) e201900562; DOI: 10.26508/lsa.201900562
In this Issue
Volume 3, No. 7
July 2020
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.